SCHEMBL10029543

SCHEMBL10029543

Cc1ccc(C[C@H](NC(=O)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@H](C)O)C(C)C)cc1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CTSD P07339 15/20 0.57
▸ REN P00797 5/20 0.53
▸ PSMB5 P28074 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10029542 0.91 REN (0.59) CTSDRENPSMB5
SCHEMBL10029541 0.90 CTSD (0.56) CTSDRENPSMB5
SCHEMBL10029540 0.90 CTSD (0.68) CTSDRENPSMB5
SCHEMBL10029544 0.89 CTSD (0.59) CTSDRENPSMB5
SCHEMBL10029538 0.83 CTSD (0.56) CTSDRENPSMB5
SCHEMBL10029539 0.82 CTSD (0.52) CTSDREN
SCHEMBL10029533 0.80 CTSD (0.53) CTSDRENPSMB5
SCHEMBL10029526 0.79 CTSD (0.51) CTSD
SCHEMBL8479400 0.78 REN (0.73) CTSDREN
SCHEMBL10029534 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809498-B2 Pepstatin A derivatives FREIE UNIVERSITAET BERLIN (DE) 2014-08-19 — — US disclosed
US-20120016103-A1 PEPSTATIN A DERIVATIVES FREIE UNIVERSITAET BERLIN 2012-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016103-A1 PEPSTATIN A DERIVATIVES PEPD, ANPEP, VIP CTSD 845/4885REN 433/4885PSMB5 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback